Sahlgrenska Cardiomyopathy Project

N/AEnrolling By InvitationNCT03527342

Göteborg University3,000 enrolled

Overview

This is a joint project by Sahlgrenska University Hospital: Sahlgrenska, Östra and Mölndal. Our objective is to diagnose and map patients with well phenotyped cardiomyopathies (CMP) including in depth clinical and molecular phenotyping to enable earlier and specific treatment. The project will serve as: 1. resource for diagnostic and therapeutic trials 2. common biomaterial bank 3. resource for detailed molecular analyses on patients' biomaterials and patient specific symptoms and examination results

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Dilated Cardiomyopathies Hypertrophic Cardiomyopathy Restrictive Cardiomyopathy Arrhythmogenic Right Ventricular Cardiomyopathy Myocarditis Sarcoidosis With Myocarditis Giant Cell Myocarditis

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with primary cardiomyopathies including hereditary and inflammatory dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, left ventricular non-compaction cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, myocarditis, giant cell myocarditis, sarcoidosis and amyloidosis engaging the heart Exclusion Criteria: * Patient with other preexisting cardiac diseases such as significant valvular, ischemic or pericardial disease before they receive a cardiomyopathy diagnose * patients \< 18 years

Sahlgrenska Cardiomyopathy Project

Overview

Conditions

Eligibility

Locations (1)

Outcomes

Primary Outcomes